PEspeaks

Jun 01, 2012
Pharmaceutical Executive
Legislation to reauthorize Food and Drug Administration user fee programs sailed through the House and Senate last month, setting the stage for leading legislators to resolve their differences and agree on a compromise measure.
May 25, 2012
Pharmaceutical Executive
Every company director, executive and department head remembers the first time they tackled a real management issue. Perhaps it was settling a team dispute, or keeping the director at bay to protect the morale of the team.
May 24, 2012
Pharmaceutical Executive
Will France’s new socialist president, François Hollande, prove too strong for pharma’s taste? Reflector, Pharm Exec’s EU correspondent, reports.
May 21, 2012
Pharmaceutical Executive
By admin
A new report from ZS Associates explores the efficacy and impact of physician incentive compensation on the delivery of quality care; when incentives fall short, so can patient outcomes
May 21, 2012
Pharmaceutical Executive
Recognizing that traditional market forces – namely incentives related to intellectual property and a steady demand for products – have failed in developing countries, the World Health Organization (WHO) asked a member state-nominated group to come up with ways to fund R&D and pay for the treatment of neglected diseases in the world’s poorest nations.
May 11, 2012
Pharmaceutical Executive
A keynote speaker at the 9thAnnual SaS Health Care & Life Sciences Executive Conference on May 10, ‘disruptive’ author of The Innovator’s Dilemma and Harvard business professor Clayton Christensen sat down with PharmExec to discuss the future of the pharmaceutical industry, and what Mitt Romney could bring to the White House.
May 11, 2012
Pharmaceutical Executive
CBI conference highlights three turnaround strategies to plug the gaps in patient adherence.
May 11, 2012
Pharmaceutical Executive
While French politics has taken a decisive shift to the left with the election of the country’s first socialist president for 17 years
May 09, 2012
Pharmaceutical Executive
By admin
For pharma, simply moving traditional marketing materials and tactics from print to online is not enough—a true digital transition must be interactive to be effective.
May 09, 2012
Pharmaceutical Executive
Drug shortages, particularly those for sterile injectable drugs, took center stage last year. In response, industry and the federal government, including FDA, took steps to address the problem.
native1_300x100
lorem ipsum